Search results
Results from the WOW.Com Content Network
In late 2015, Carreyrou began a series of investigative articles on Theranos, published in The Wall Street Journal on the blood-testing startup founded by Elizabeth Holmes. The articles questioned the company's claim to be able to run a wide range of lab tests from a tiny sample of blood from a finger prick.
Theranos founder Elizabeth Holmes began serving an 11-year sentence in a Texas federal prison on Tuesday, completing a dramatic fall for a biotech entrepreneur who once dazzled Silicon Valley with ...
Theranos Inc. (/ ˈ θ ɛr. ə n. oʊ s /) was an American privately held corporation [5] that was touted as a breakthrough health technology company. Founded in 2003 by then 19-year-old Elizabeth Holmes, Theranos raised more than US$700 million from venture capitalists and private investors, resulting in a $9 billion valuation at its peak in 2013 and 2014.
On June 15, 2018, following an investigation by the U.S. Attorney's Office for the Northern District of California in San Francisco that lasted more than two years, a federal grand jury indicted Holmes and former Theranos chief operating officer and president, Ramesh "Sunny" Balwani, on nine counts of wire fraud and two counts of conspiracy to commit wire fraud.
Balwani, 57, faces a dozen wire fraud and conspiracy charges tied to his role as an executive in Theranos, which imploded after it became clear that its blood-testing technology did not work as ...
She founded DotLab in 2016, a year after a scathing WSJ report exposed Elizabeth Holmes’ Theranos. “The scientific bar, the technological bar was raised because of the fraud that looks like it ...
Theranos founder Elizabeth Holmes (center) arrives to attend her fraud trial at federal court in San Jose, California, U.S. January 3, 2022. REUTERS/Brittany Hosea-Small (Brittany Hosea-Small ...
In 2018, the U.S. Securities and Exchange Commission (SEC) charged Theranos, Holmes, and former Theranos chief operating officer (COO) Ramesh "Sunny" Balwani with raising $700 million from investors through a fraud involving false or exaggerated claims about the accuracy of the company's blood-testing technology; Holmes settled the charges by ...